Healthpeak Properties lands new tenant for San Francisco campus development
Janssen BioPharma will occupy about 60% of phase II at The Shore at Sierra Point upon its completion in January 2022.
Healthpeak Properties Inc. signed a long-term lease with Janssen BioPharma Inc.
The company, which is part of the Johnson & Johnson Family of Cos., will occupy roughly 60% of phase II at The Shore at Sierra Point campus in South San Francisco on completion of its construction, expected in January 2022.
Under the terms of the lease, Janssen has expansion rights t...